Skip Navigation LinksHome > August 2014 - Volume 33 - Issue 8 > Safety and Tolerability of High-dose Weekly Liposomal Amphot...
Pediatric Infectious Disease Journal:
doi: 10.1097/INF.0000000000000335
Antimicrobial Reports

Safety and Tolerability of High-dose Weekly Liposomal Amphotericin B Antifungal Prophylaxis

Hand, Elizabeth O. PharmD, BCPS*†‡; Ramanathan, Meenakshi R. PharmD*†§

Collapse Box

Abstract

Children with hematologic malignancies are at an increased risk of invasive fungal infections and a greater risk has been seen with exposure to building construction. Prophylaxis with high-dose (IV) liposomal amphotericin B (L-AmB) 10 mg/kg once weekly was initiated in our high risk children based on previous pharmacokinetic studies. This treatment regimen was associated with a 26% incidence of adverse infusion reactions.

© 2014 by Lippincott Williams & Wilkins, Inc.

Login

Article Tools

Share

Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.